Table of Content

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 27
1.3 STUDY SCOPE 27
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 27
1.3.2 INCLUSIONS AND EXCLUSIONS 28
1.3.3 YEARS CONSIDERED 28
1.4 CURRENCY CONSIDERED 28
1.5 UNIT CONSIDERED 29
1.6 STAKEHOLDERS 29
1.7 LIMITATIONS 29
1.8 SUMMARY OF CHANGES 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.1.1 SECONDARY DATA 31
2.1.1.1 List of key secondary sources 31
2.1.1.2 Key data from secondary sources 31
2.1.2 PRIMARY DATA 32
2.1.2.1 List of primary interview participants 32
2.1.2.2 Breakdown of primaries 32
2.1.2.3 Key data from primary sources 33
2.1.2.4 Key industry insights 33
2.1.3 SECONDARY AND PRIMARY RESEARCH 34
2.2 MARKET SIZE ESTIMATION METHODOLOGY 34
2.2.1 BOTTOM-UP APPROACH 36
2.2.1.1 Approach to arrive at market size through bottom-up analysis (demand side) 36
2.2.2 TOP-DOWN APPROACH 37
2.2.2.1 Approach to arrive at market size through top-down analysis (supply side) 37
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 38
2.4 RESEARCH ASSUMPTIONS 39
2.5 RESEARCH LIMITATIONS 39
2.6 RISK ANALYSIS 40
3 EXECUTIVE SUMMARY 41
?
4 PREMIUM INSIGHTS 44
4.1 ATTRACTIVE GROWTH OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 44
4.2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE 45
4.3 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE 45
4.4 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
5.2.1 DRIVERS 48
5.2.1.1 Growing rate of chronic diseases 48
5.2.1.2 Adoption of modular manufacturing setups 48
5.2.1.3 Increasing implementation and adoption of regulatory guidelines 48
5.2.2 RESTRAINTS 50
5.2.2.1 Rising adoption of refurbished equipment 50
5.2.3 OPPORTUNITIES 50
5.2.3.1 Growing demand for personalized medicines 50
5.2.3.2 Rising demand for biopharmaceuticals 51
5.2.4 CHALLENGES 51
5.2.4.1 Adherence to multiple regulations and standards 51
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 52
5.4 PRICING ANALYSIS 53
5.4.1 INDICATIVE PRICING OF KEY PLAYERS, BY EQUIPMENT TYPE, 2023 53
5.4.2 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, 2019–2023 54
5.4.3 AVERAGE SELLING PRICE TREND, BY REGION, 2019–2023 55
5.5 VALUE CHAIN ANALYSIS 56
5.6 ECOSYSTEM ANALYSIS 58
5.7 IMPACT OF AI/GENERATIVE AI ON PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 59
5.8 TECHNOLOGY ANALYSIS 60
5.8.1 KEY TECHNOLOGIES 60
5.8.1.1 Digital twin 60
5.8.1.2 Automation and robotics 60
5.8.1.3 IoT 61
5.8.2 COMPLEMENTARY TECHNOLOGIES 61
5.8.2.1 3D printing 61
5.8.3 ADJACENT TECHNOLOGIES 61
5.8.3.1 CAD and CAM 61
5.9 PATENT ANALYSIS 62
5.10 TRADE ANALYSIS 64
5.10.1 IMPORT DATA (HS CODE 842230) 64
5.10.2 EXPORT DATA (HS CODE 842230) 65
5.11 KEY CONFERENCES AND EVENTS, 2025–2026 66
5.12 CASE STUDIES 67
5.12.1 ZAMBON COMPANY S.P.A. AND IMA ACTIVE COLLABORATED ON PROCESS OPTIMIZATION PROJECT TO ENHANCE BATCH CONSISTENCY AND QUALITY 67
5.12.2 ACG HELPED INDIAN PHARMACEUTICAL COMPANY RETROFIT B MAX MACHINE WITH NITROGEN-ENHANCED PURGING SYSTEM 68
5.12.3 SYNTEGON PROVIDED JIANGSU WITH AIM 5022S PLATFORM TO ENHANCE INSPECTION EFFICIENCY AND ACCURACY 68
5.13 REGULATIONS LANDSCAPE 69
5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
5.13.2 STANDARDS 71
5.14 PORTER’S FIVE FORCES ANALYSIS 72
5.14.1 BARGAINING POWER OF SUPPLIERS 73
5.14.2 BARGAINING POWER OF BUYERS 73
5.14.3 THREAT OF NEW ENTRANTS 73
5.14.4 THREAT OF SUBSTITUTES 73
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 74
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 74
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 74
5.15.2 BUYING CRITERIA 75
6 PHARMACEUTICAL MANUFACTURING EQUIPMENT SUPPLIERS AND AFTERMARKET SUPPLIERS 76
6.1 INTRODUCTION 76
6.2 ORIGINAL EQUIPMENT MANUFACTURERS 76
6.3 AFTERMARKET SUPPLIERS 77
7 MAJOR PHARMACEUTICAL EQUIPMENT MANUFACTURING PROCESSES 78
7.1 INTRODUCTION 78
7.2 FORMULATION PROCESS 79
7.3 TABLETING AND ENCAPSULATION PROCESS 79
7.4 ASEPTIC PROCESS 80
7.5 PACKAGING PROCESS 80
7.6 QUALITY CONTROL PROCESS 80
8 END USERS OF PHARMACEUTICAL MANUFACTURING EQUIPMENT 82
8.1 INTRODUCTION 82
8.2 PHARMACEUTICAL MANUFACTURING COMPANIES 82
8.3 CONTRACT MANUFACTURING ORGANIZATIONS 83
9 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY END-PRODUCT TYPE 84
9.1 INTRODUCTION 85
9.2 SOLID 86
9.2.1 ONGOING TECHNOLOGICAL INNOVATIONS TO DRIVE MARKET 86
9.3 LIQUID 88
9.3.1 RISING APPLICATION FOR UNSTABLE DRUGS IN SOLID FORM
TO BOOST DEMAND 88
10 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE 90
10.1 INTRODUCTION 91
10.2 PACKAGING MACHINES 93
10.2.1 RISING NEED TO ENSURE PROTECTION AGAINST DAMAGE AND CONTAMINATION TO FUEL MARKET GROWTH 93
10.3 FILLING MACHINES 97
10.3.1 GROWING NEED FOR COMPLIANCE WITH STRINGENT REGULATORY STANDARDS TO FOSTER MARKET GROWTH 97
10.4 SPRAY DRYING EQUIPMENT 101
10.4.1 PRESSING NEED TO PRODUCE HIGH-QUALITY DRUG PRODUCTS TO FUEL MARKET GROWTH 101
10.5 MIXING AND BLENDING MACHINES 104
10.5.1 ABILITY TO PROVIDE CONTROLLED AND CONSISTENT AGITATION AND SHEAR FORCES TO ENSURE HOMOGENEITY OF DRUG FORMULATION TO BOOST DEMAND 104
10.6 MILLING EQUIPMENT 108
10.6.1 RISING NEED TO REDUCE PARTICLE SIZE OF DRUG FORMULATIONS TO FOSTER MARKET GROWTH 108
10.7 EXTRUSION EQUIPMENT 112
10.7.1 ELEVATING USE TO PRODUCE VARIOUS DOSAGE FORMS TO FUEL MARKET GROWTH 112
10.8 TABLET COMPRESSION PRESSES 115
10.8.1 INCREASING PREFERENCE FOR SOLID DOSAGE FORMS TO DRIVE MARKET 115
10.9 INSPECTION EQUIPMENT 119
10.9.1 SURGING NEED TO ENSURE QUALITY AND INTEGRITY OF DRUG PRODUCTS TO FOSTER MARKET GROWTH 119
10.10 GRANULATION EQUIPMENT 123
10.10.1 ABILITY TO IMPROVE OVERALL STABILITY AND BIOAVAILABILITY OF DRUGS TO BOOST DEMAND 123
10.11 STERILIZATION EQUIPMENT 126
10.11.1 GROWING DEMAND FOR CONTAMINATION-FREE DRUGS AND PRODUCTS TO DRIVE MARKET 126
?
11 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION 130
11.1 INTRODUCTION 131
11.2 NORTH AMERICA 133
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 133
11.2.2 US 136
11.2.2.1 Government-led initiatives to advance pharmaceutical manufacturing capacity to drive market 136
11.2.3 CANADA 138
11.2.3.1 Rising emphasis on strengthening domestic manufacturing capabilities to foster market growth 138
11.2.4 MEXICO 139
11.2.4.1 Increasing focus on streamlining pharmaceutical regulatory processes to fuel market growth 139
11.3 EUROPE 141
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 141
11.3.2 UK 143
11.3.2.1 Rising emphasis on developing advanced manufacturing equipment to offer lucrative growth opportunities 143
11.3.3 GERMANY 145
11.3.3.1 Escalating demand for branded and generic drugs to foster market growth 145
11.3.4 FRANCE 146
11.3.4.1 Government-led policies to encourage investment and innovation in pharmaceutical manufacturing industry to accelerate demand 146
11.3.5 ITALY 148
11.3.5.1 Growing focus on establishing pharmaceutical manufacturing facilities to create significant growth opportunities 148
11.3.6 REST OF EUROPE 149
11.4 ASIA PACIFIC 151
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 151
11.4.2 CHINA 154
11.4.2.1 Surging FDIs and regulatory reforms to streamline drug approvals to offer lucrative growth opportunities 154
11.4.3 JAPAN 156
11.4.3.1 Increasing demand for innovative pharmaceutical manufacturing solutions to fuel market growth 156
11.4.4 INDIA 157
11.4.4.1 Government-led initiatives to strengthen domestic manufacturing to boost demand 157
11.4.5 SOUTH KOREA 159
11.4.5.1 Low import tariffs and enhanced regulatory transparency to attract foreign investments to foster market growth 159
11.4.6 REST OF ASIA PACIFIC 160
?
11.5 ROW 161
11.5.1 MACROECONOMIC OUTLOOK FOR ROW 161
11.5.2 MIDDLE EAST 164
11.5.2.1 Expanding pharmaceutical manufacturing infrastructure to offer growth opportunities 164
11.5.2.2 GCC 164
11.5.2.3 Rest of Middle East 164
11.5.3 AFRICA 166
11.5.3.1 Rising investment in local pharmaceutical manufacturing to fuel market growth 166
11.5.4 SOUTH AMERICA 166
11.5.4.1 Introduction of tax incentives to strengthen pharmaceutical manufacturing to support market growth 166
12 COMPETITIVE LANDSCAPE 167
12.1 OVERVIEW 167
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2024 167
12.3 REVENUE ANALYSIS, 2019–2023 169
12.4 MARKET SHARE ANALYSIS, 2023 169
12.5 COMPANY VALUATION AND FINANCIAL METRICS, 2024 172
12.6 BRAND/PRODUCT COMPARISON 174
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 175
12.7.1 STARS 175
12.7.2 EMERGING LEADERS 175
12.7.3 PERVASIVE PLAYERS 175
12.7.4 PARTICIPANTS 175
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 177
12.7.5.1 Company footprint 177
12.7.5.2 Region footprint 178
12.7.5.3 Primary packaging equipment footprint 179
12.7.5.4 Secondary packaging equipment footprint 180
12.7.5.5 Type footprint 181
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 182
12.8.1 PROGRESSIVE COMPANIES 182
12.8.2 RESPONSIVE COMPANIES 182
12.8.3 DYNAMIC COMPANIES 182
12.8.4 STARTING BLOCKS 182
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 184
12.8.5.1 Detailed list of key startups/SMEs 184
12.8.5.2 Competitive benchmarking of key startups/SMEs 184
12.9 COMPETITIVE SCENARIO 185
12.9.1 PRODUCT LAUNCHES 185
12.9.2 DEALS 186
13 COMPANY PROFILES 187
13.1 KEY PLAYERS 187
13.1.1 GEA GROUP AKTIENGESELLSCHAFT 187
13.1.1.1 Business overview 187
13.1.1.2 Products/Solutions/Services offered 189
13.1.1.3 Recent developments 190
13.1.1.3.1 Product launches 190
13.1.1.3.2 Deals 190
13.1.1.4 MnM view 191
13.1.1.4.1 Key strengths/Right to win 191
13.1.1.4.2 Strategic choices 191
13.1.1.4.3 Weaknesses/Competitive threats 191
13.1.2 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A. 192
13.1.2.1 Business overview 192
13.1.2.2 Products/Solutions/Services offered 193
13.1.2.3 Recent developments 194
13.1.2.3.1 Deals 194
13.1.2.4 MnM view 194
13.1.2.4.1 Key strengths/Right to win 194
13.1.2.4.2 Strategic choices 195
13.1.2.4.3 Weaknesses/Competitive threats 195
13.1.3 SYNTEGON TECHNOLOGY GMBH 196
13.1.3.1 Business overview 196
13.1.3.2 Products/Solutions/Services offered 197
13.1.3.3 Recent developments 197
13.1.3.3.1 Product launches 197
13.1.3.3.2 Deals 198
13.1.3.3.3 Expansions 199
13.1.3.4 MnM view 199
13.1.3.4.1 Key strengths/Right to win 199
13.1.3.4.2 Strategic choices 199
13.1.3.4.3 Weaknesses/Competitive threats 199
13.1.4 ACG 200
13.1.4.1 Business overview 200
13.1.4.2 Products/Solutions/Services offered 200
13.1.4.3 Recent developments 201
13.1.4.3.1 Deals 201
13.1.4.3.2 Expansions 202
13.1.4.4 MnM view 202
13.1.4.4.1 Key strengths/Right to win 202
13.1.4.4.2 Strategic choices 202
13.1.4.4.3 Weaknesses/Competitive threats 202
13.1.5 THERMO FISHER SCIENTIFIC INC. 203
13.1.5.1 Business overview 203
13.1.5.2 Products/Solutions/Services offered 205
13.1.5.3 Recent developments 205
13.1.5.3.1 Deals 205
13.1.5.3.2 Expansions 206
13.1.5.4 MnM view 207
13.1.5.4.1 Key strengths/Right to win 207
13.1.5.4.2 Strategic choices 207
13.1.5.4.3 Weaknesses/Competitive threats 207
13.1.6 ROMACO GROUP 208
13.1.6.1 Business overview 208
13.1.6.2 Products/Solutions/Services offered 209
13.1.6.3 Recent developments 210
13.1.6.3.1 Product launches 210
13.1.6.3.2 Deals 210
13.1.7 K?RBER AG 211
13.1.7.1 Business overview 211
13.1.7.2 Products/Solutions/Services offered 212
13.1.7.3 Recent developments 213
13.1.7.3.1 Deals 213
13.1.7.3.2 Expansions 214
13.1.8 MARCHESINI GROUP S.P.A. 215
13.1.8.1 Business overview 215
13.1.8.2 Products/Solutions/Services offered 215
13.1.8.3 Recent developments 216
13.1.8.3.1 Product launches 216
13.1.8.3.2 Deals 217
13.1.9 MG2 S.R.L. 218
13.1.9.1 Business overview 218
13.1.9.2 Products/Solutions/Services offered 218
13.1.9.3 Recent developments 220
13.1.9.3.1 Product launches 220
13.1.10 GLATT GMBH 221
13.1.10.1 Business overview 221
13.1.10.2 Products/Solutions/Services offered 221
13.2 OTHER PLAYERS 222
13.2.1 BAUSCH+STR?BEL SE + CO. KG 222
13.2.2 COPERION GMBH 223
13.2.3 ELIZABETH COMPANIES 224
13.2.4 FETTE COMPACTING 225
13.2.5 FREUND 226
13.2.6 KORSCH AG 227
13.2.7 L.B. BOHLE MASCHINEN UND VERFAHREN GMBH 228
13.2.8 LFA MACHINES 229
13.2.9 CVC TECHNOLOGIES, INC. 230
13.2.10 OHARA TECHNOLOGIES 231
13.2.11 PRISM PHARMA MACHINERY 232
13.2.12 SAINTYCO 233
13.2.13 SILVERSON 234
13.2.14 YENCHEN MACHINERY CO., LTD 234
13.2.15 QUALICAPS 235
13.2.16 COESIA S.P.A. 236
13.2.17 UHLMANN 237
13.2.18 AUTOMATED SYSTEMS OF TACOMA, LLC 238
14 APPENDIX 239
14.1 INSIGHTS FROM INDUSTRY EXPERTS 239
14.2 DISCUSSION GUIDE 240
14.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 243
14.4 CUSTOMIZATION OPTIONS 245
14.5 RELATED REPORTS 245
14.6 AUTHOR DETAILS 246



List of Figures

FIGURE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SEGMENTATION 27
FIGURE 2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH DESIGN 30
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY (SUPPLY SIDE): REVENUE GENERATED FROM PHARMACEUTICAL PACKAGING MACHINES 35
FIGURE 4 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
BOTTOM-UP APPROACH 36
FIGURE 5 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: TOP-DOWN APPROACH 37
FIGURE 6 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DATA TRIANGULATION 38
FIGURE 7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
RESEARCH ASSUMPTIONS 39
FIGURE 8 PACKAGING MACHINES TO HOLD DOMINANT MARKET SHARE IN 2029 42
FIGURE 9 SOLID SEGMENT TO CLAIM LARGEST MARKET SHARE IN 2024 42
FIGURE 10 ASIA PACIFIC DOMINATED MARKET IN 2023 43
FIGURE 11 GROWING DEMAND FOR FLEXIBLE PHARMACEUTICAL MANUFACTURING TO OFFER LUCRATIVE GROWTH OPPORTUNITIES 44
FIGURE 12 PACKAGING MACHINES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 45
FIGURE 13 LIQUID SEGMENT TO EXHIBIT HIGHER CAGR DURING FORECAST PERIOD 45
FIGURE 14 INDIA TO REGISTER HIGHEST CAGR IN GLOBAL MARKET DURING
FORECAST PERIOD 46
FIGURE 15 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47
FIGURE 16 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
IMPACT ANALYSIS OF DRIVERS 49
FIGURE 17 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
IMPACT ANALYSIS OF RESTRAINTS 50
FIGURE 18 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
IMPACT ANALYSIS OF OPPORTUNITIES 51
FIGURE 19 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
IMPACT ANALYSIS OF CHALLENGES 52
FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 52
FIGURE 21 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, 2019–2023 54
FIGURE 22 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES BY REGION, 2019–2023 55
FIGURE 23 VALUE CHAIN ANALYSIS 56
FIGURE 24 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET ECOSYSTEM ANALYSIS 58
FIGURE 25 IMPACT OF AI/GENERATIVE AI ON PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 59
FIGURE 26 PATENTS APPLIED AND GRANTED, 2014–2023 62
FIGURE 27 IMPORT DATA FOR HS CODE 842230-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 64
FIGURE 28 EXPORT DATA FOR HS CODE 842230-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 65
FIGURE 29 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 72
FIGURE 30 INFLUENCE OF STAKEHOLDERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT FOR END-PRODUCT TYPE 74
FIGURE 31 KEY BUYING CRITERIA FOR PHARMACEUTICAL MANUFACTURING EQUIPMENT FOR END-PRODUCT TYPES 75
FIGURE 32 SOLID SEGMENT TO HOLD LARGER MARKET SHARE IN 2024 85
FIGURE 33 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE 91
FIGURE 34 PACKAGING MACHINES TO RECORD HIGHEST CAGR DURING FORECAST PERIOD 91
FIGURE 35 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION 131
FIGURE 36 ASIA PACIFIC TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024 132
FIGURE 37 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING
EQUIPMENT MARKET SNAPSHOT 134
FIGURE 38 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT 142
FIGURE 39 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT 152
FIGURE 40 SOUTH AMERICA TO DOMINATE MARKET IN ROW REGION IN 2024 162
FIGURE 41 PHARMACEUTICAL PACKAGING MACHINES MARKET: REVENUE ANALYSIS
OF KEY PLAYERS, 2019–2023 169
FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS OFFERING PHARMACEUTICAL PACKAGING MACHINES, 2023 170
FIGURE 43 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
COMPANY VALUATION, 2024 172
FIGURE 44 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: FINANCIAL METRICS (EV/EBITDA), 2024 173
FIGURE 45 PHARMACEUTICAL PACKAGING MACHINES MARKET: BRAND/PRODUCT COMPARISON 174
FIGURE 46 PHARMACEUTICAL PACKAGING MACHINES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 176
FIGURE 47 PHARMACEUTICAL PACKAGING MACHINES MARKET: COMPANY FOOTPRINT 177
FIGURE 48 PHARMACEUTICAL PACKAGING MACHINES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 183
FIGURE 49 GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT 188
FIGURE 50 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 204
FIGURE 51 K?RBER AG: COMPANY SNAPSHOT 212

List of Tables

TABLE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RISK ANALYSIS 40
TABLE 2 INDICATIVE PRICING OF PHARMACEUTICAL MANUFACTURING EQUIPMENT OFFERED BY KEY PLAYERS, BY EQUIPMENT TYPE, 2023 (USD) 53
TABLE 3 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, 2019–2023 (USD) 54
TABLE 4 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES BY REGION, 2019–2023 (USD) 55
TABLE 5 ROLES OF COMPANIES IN PHARMACEUTICAL MANUFACTURING
EQUIPMENT ECOSYSTEM 58
TABLE 6 LIST OF MAJOR PATENTS 63
TABLE 7 IMPORT DATA FOR HS CODE 842230-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD MILLION) 65
TABLE 8 EXPORT DATA FOR HS CODE 842230-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD MILLION) 66
TABLE 9 LIST OF KEY CONFERENCES AND EVENTS, 2025–2026 66
TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 69
TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 70
TABLE 12 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 70
TABLE 13 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 71
TABLE 14 STANDARDS PERTAINING TO PHARMACEUTICAL MANUFACTURING EQUIPMENT 71
TABLE 15 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 72
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END-PRODUCT TYPES 74
TABLE 17 KEY BUYING CRITERIA FOR END-PRODUCT TYPES 75
TABLE 18 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY END-PRODUCT TYPE, 2020–2023 (USD MILLION) 86
TABLE 19 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY END-PRODUCT TYPE, 2024–2029 (USD MILLION) 86
TABLE 20 SOLID: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 87
TABLE 21 SOLID: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 87
TABLE 22 LIQUID: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 88
TABLE 23 LIQUID: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 89
TABLE 24 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (THOUSAND UNITS) 92
TABLE 25 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (THOUSAND UNITS) 92
TABLE 26 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 92
TABLE 27 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 93
TABLE 28 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION) 94
TABLE 29 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION) 94
TABLE 30 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION) 94
TABLE 31 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION) 94
TABLE 32 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION) 95
TABLE 33 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION) 95
TABLE 34 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION) 95
TABLE 35 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION) 96
TABLE 36 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION) 96
TABLE 37 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION) 96
TABLE 38 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY END-PRODUCT TYPE, 2020–2023 (USD MILLION) 97
TABLE 39 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY END-PRODUCT TYPE, 2024–2029 (USD MILLION) 98
TABLE 40 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY REGION, 2020–2023 (USD MILLION) 98
TABLE 41 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY REGION, 2024–2029 (USD MILLION) 98
TABLE 42 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION) 99
TABLE 43 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION) 99
TABLE 44 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION) 99
TABLE 45 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION) 100
TABLE 46 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION) 100
TABLE 47 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION) 100
TABLE 48 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION) 101
TABLE 49 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION) 101
TABLE 50 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION) 102
TABLE 51 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION) 102
TABLE 52 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION) 102
TABLE 53 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION) 103
TABLE 54 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION) 103
TABLE 55 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION) 103
TABLE 56 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION) 104
TABLE 57 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION) 104
TABLE 58 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION) 105
TABLE 59 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION) 105
TABLE 60 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION) 105
TABLE 61 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION) 106
TABLE 62 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY 2020–2023 (USD MILLION) 106
TABLE 63 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY 2024–2029 (USD MILLION) 106
TABLE 64 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION) 107
TABLE 65 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION) 107
TABLE 66 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION) 107
TABLE 67 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION) 108
TABLE 68 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION) 108
TABLE 69 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION) 109
TABLE 70 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION) 109
TABLE 71 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION) 109
TABLE 72 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION) 110
TABLE 73 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION) 110
TABLE 74 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION) 110
TABLE 75 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION) 111
TABLE 76 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION) 111
TABLE 77 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION) 111
TABLE 78 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION) 112
TABLE 79 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION) 112
TABLE 80 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION) 113
TABLE 81 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION) 113
TABLE 82 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION) 113
TABLE 83 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION) 114
TABLE 84 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION) 114
TABLE 85 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION) 114
TABLE 86 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION) 115
TABLE 87 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION) 115
TABLE 88 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION) 116
TABLE 89 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION) 116
TABLE 90 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION) 116
TABLE 91 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION) 117
TABLE 92 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY 2020–2023 (USD MILLION) 117
TABLE 93 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY 2024–2029 (USD MILLION) 117
TABLE 94 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION) 118
TABLE 95 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION) 118
TABLE 96 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION) 118
TABLE 97 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION) 119
TABLE 98 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION) 120
TABLE 99 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION) 120
TABLE 100 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION) 120
TABLE 101 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION) 120
TABLE 102 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION) 121
TABLE 103 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION) 121
TABLE 104 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION) 121
TABLE 105 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION) 122
TABLE 106 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION) 122
TABLE 107 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION) 122
TABLE 108 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION) 123
TABLE 109 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION) 123
TABLE 110 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION) 124
TABLE 111 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION) 124
TABLE 112 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION) 124
TABLE 113 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION) 124
TABLE 114 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION) 125
TABLE 115 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION) 125
TABLE 116 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION) 125
TABLE 117 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION) 126
TABLE 118 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION) 126
TABLE 119 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION) 127
TABLE 120 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION) 127
TABLE 121 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION) 127
TABLE 122 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION) 127
TABLE 123 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION) 128
TABLE 124 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION) 128
TABLE 125 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION) 128
TABLE 126 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION) 129
TABLE 127 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION) 129
TABLE 128 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION 2020–2023 (USD MILLION) 132
TABLE 129 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION 2024–2029 (USD MILLION) 132
TABLE 130 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY COUNTRY, 2020–2023 (USD MILLION) 134
TABLE 131 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY COUNTRY, 2024–2029 (USD MILLION) 135
TABLE 132 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 135
TABLE 133 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 136
TABLE 134 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 137
TABLE 135 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 137
TABLE 136 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 138
TABLE 137 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 139
TABLE 138 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 140
TABLE 139 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 140
TABLE 140 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY COUNTRY, 2020–2023 (USD MILLION) 143
TABLE 141 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY COUNTRY, 2024–2029 (USD MILLION) 143
TABLE 142 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 144
TABLE 143 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 144
TABLE 144 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 145
TABLE 145 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 146
TABLE 146 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 147
TABLE 147 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 147
TABLE 148 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 148
TABLE 149 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 149
TABLE 150 REST OF EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 150
TABLE 151 REST OF EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 150
TABLE 152 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY COUNTRY, 2020–2023 (USD MILLION) 153
TABLE 153 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY COUNTRY, 2024–2029 (USD MILLION) 153
TABLE 154 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 153
TABLE 155 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 154
TABLE 156 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 155
TABLE 157 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 155
TABLE 158 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 156
TABLE 159 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 157
TABLE 160 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 158
TABLE 161 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 158
TABLE 162 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 159
TABLE 163 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 160
TABLE 164 REST OF ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 160
TABLE 165 REST OF ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 161
TABLE 166 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION) 162
TABLE 167 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION) 162
TABLE 168 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION) 163
TABLE 169 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION) 163
TABLE 170 MIDDLE EAST: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY COUNTRY, 2020–2023 (USD MILLION) 165
TABLE 171 MIDDLE EAST: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET BY COUNTRY, 2024–2029 (USD MILLION) 165
TABLE 172 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2022–2024 167
TABLE 173 PHARMACEUTICAL PACKAGING MACHINES MARKET:
DEGREE OF COMPETITION, 2023 170
TABLE 174 PHARMACEUTICAL PACKAGING MACHINES MARKET: REGION FOOTPRINT 178
TABLE 175 PHARMACEUTICAL PACKAGING MACHINES MARKET: PRIMARY PACKAGING EQUIPMENT FOOTPRINT 179
TABLE 176 PHARMACEUTICAL PACKAGING MACHINES MARKET: SECONDARY PACKAGING EQUIPMENT FOOTPRINT 180
TABLE 177 PHARMACEUTICAL PACKAGING MACHINES MARKET: TYPE FOOTPRINT 181
TABLE 178 PHARMACEUTICAL PACKAGING MACHINES MARKET: DETAILED LIST
OF KEY STARTUPS/SMES 184
TABLE 179 PHARMACEUTICAL PACKAGING MACHINES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 184
TABLE 180 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2024 185
TABLE 181 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
DEALS, JANUARY 2022–OCTOBER 2024 186
TABLE 182 GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW 187
TABLE 183 GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 189
TABLE 184 GEA GROUP AKTIENGESELLSCHAFT: PRODUCT LAUNCHES 190
TABLE 185 GEA GROUP AKTIENGESELLSCHAFT: DEALS 190
TABLE 186 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A.: COMPANY OVERVIEW 192
TABLE 187 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A.: PRODUCT/SOLUTIONS/SERVICES OFFERED 193
TABLE 188 I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A.: DEALS 194
TABLE 189 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW 196
TABLE 190 SYNTEGON TECHNOLOGY GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 197
TABLE 191 SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES 197
TABLE 192 SYNTEGON TECHNOLOGY GMBH: DEALS 198
TABLE 193 SYNTEGON TECHNOLOGY GMBH: EXPANSIONS 199
TABLE 194 ACG: COMPANY OVERVIEW 200
TABLE 195 ACG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 200
TABLE 196 ACG: DEALS 201
TABLE 197 ACG: EXPANSIONS 202
TABLE 198 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 203
TABLE 199 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 205
TABLE 200 THERMO FISHER SCIENTIFIC INC.: DEALS 205
TABLE 201 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS 206
TABLE 202 ROMACO GROUP: COMPANY OVERVIEW 208
TABLE 203 ROMACO GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 209
TABLE 204 ROMACO GROUP: PRODUCT LAUNCHES 210
TABLE 205 ROMACO GROUP: DEALS 210
TABLE 206 K?RBER AG: COMPANY OVERVIEW 211
TABLE 207 K?RBER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 212
TABLE 208 K?RBER AG: DEALS 213
TABLE 209 K?RBER AG: EXPANSIONS 214
TABLE 210 MARCHESINI GROUP S.P.A.: COMPANY OVERVIEW 215
TABLE 211 MARCHESINI GROUP S.P.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 215
TABLE 212 MARCHESINI GROUP S.P.A.: PRODUCT LAUNCHES 216
TABLE 213 MARCHESINI GROUP S.P.A.: DEALS 217
TABLE 214 MG2 S.R.L.: COMPANY OVERVIEW 218
TABLE 215 MG2 S.R.L.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 218
TABLE 216 MG2 S.R.L.: PRODUCT LAUNCHES 220
TABLE 217 GLATT GMBH: COMPANY OVERVIEW 221
TABLE 218 GLATT GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 221
TABLE 219 BAUSCH+STR?BEL SE + CO. KG: COMPANY OVERVIEW 222
TABLE 220 COPERION GMBH: COMPANY OVERVIEW 223
TABLE 221 ELIZABETH COMPANIES: COMPANY OVERVIEW 224
TABLE 222 FETTE COMPACTING: COMPANY OVERVIEW 225
TABLE 223 FREUND: COMPANY OVERVIEW 226
TABLE 224 KORSCH AG: COMPANY OVERVIEW 227
TABLE 225 L.B. BOHLE MASCHINEN UND VERFAHREN GMBH: COMPANY OVERVIEW 228
TABLE 226 LFA MACHINES: COMPANY OVERVIEW 229
TABLE 227 CVC TECHNOLOGIES, INC.: COMPANY OVERVIEW 230
TABLE 228 OHARA TECHNOLOGIES: COMPANY OVERVIEW 231
TABLE 229 PRISM PHARMA MACHINERY: COMPANY OVERVIEW 232
TABLE 230 SAINTYCO: COMPANY OVERVIEW 233
TABLE 231 SILVERSON: COMPANY OVERVIEW 234
TABLE 232 YENCHEN MACHINERY CO., LTD: COMPANY OVERVIEW 234
TABLE 233 QUALICAPS: COMPANY OVERVIEW 235
TABLE 234 COESIA S.P.A.: COMPANY OVERVIEW 236
TABLE 235 UHLMANN: COMPANY OVERVIEW 237
TABLE 236 AUTOMATED SYSTEMS OF TACOMA, LLC: COMPANY OVERVIEW 238